Filing Details

Accession Number:
0001209191-17-023543
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-29 17:13:27
Reporting Period:
2017-03-27
Filing Date:
2017-03-29
Accepted Time:
2017-03-29 17:13:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Holdings Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1632795 S. Ravi Chari One Park Plaza
Nashville TN 37203
Svp-Clinical Excellence No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-27 6,397 $5.98 7,754 No 4 M Direct
Common Stock Acquisiton 2017-03-27 1,184 $15.91 8,938 No 4 M Direct
Common Stock Acquisiton 2017-03-27 18,750 $17.33 27,688 No 4 M Direct
Common Stock Acquisiton 2017-03-27 3,125 $21.35 30,813 No 4 M Direct
Common Stock Acquisiton 2017-03-27 2,500 $22.10 33,313 No 4 M Direct
Common Stock Disposition 2017-03-27 31,956 $90.00 1,357 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 4,505 $0.00 4,505 $5.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 1,892 $0.00 1,892 $5.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 1,184 $0.00 1,184 $15.91
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 9,375 $0.00 9,375 $17.33
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 9,375 $0.00 9,375 $17.33
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 3,125 $0.00 3,125 $21.35
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-27 2,500 $0.00 2,500 $22.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-08-27 No 4 M Direct
0 2019-08-27 No 4 M Direct
0 2019-08-27 No 4 M Direct
0 2021-11-02 No 4 M Direct
0 2021-11-02 No 4 M Direct
0 2012-11-02 2021-11-02 No 4 M Direct
0 2021-11-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect By GRAT (Spouse, Trustee)
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  3. The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.
  4. Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  5. The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.
  6. The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.
  7. The option vested in three equal annual installments beginning on November 2, 2013.
  8. The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.
  9. The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.